Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9172977 | 1.00 | CHRNB4 (0.30) | CHRNB4CHRNA3 | |
| SCHEMBL25481971 | 0.83 | — | — | |
| SCHEMBL8196812 | 0.83 | HDAC7 (0.34) | — | |
| SCHEMBL7742525 | 0.83 | HDAC7 (0.34) | — | |
| SCHEMBL19160333 | 0.80 | FAAH (0.39) | — | |
| SCHEMBL15992208 | 0.80 | MMP1 (0.41) | — | |
| SCHEMBL409671 | 0.79 | USP2 (0.39) | — | |
| SCHEMBL409826 | 0.78 | KMT2A (0.31) | — | |
| SCHEMBL9292168 | 0.74 | HAO1 (0.38) | CHRNB4CHRNA3 | |
| SCHEMBL9566006 | 0.74 | KMT2A (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630570-B2 | Organometallic adduct compound and method of manufacturing integrated circuit device by using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-4130010-B1 | ZINC COMPOUND, RAW MATERIAL FOR THIN FILM FORMATION, THIN FILM, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-4067365-B1 | COMPOUND, THIN FILM-FORMING MATERIAL, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12577660-B2 | Compound, thin-film forming raw material, thin-film, and method of producing thin-film | ADEKA CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20260055507-A1 | THIN-FILM FORMING RAW MATERIAL, THIN-FILM AND METHOD OF PRODUCING THIN-FILM | ADEKA CORPORATION (JP) | 2026-02-26 | — | — | US | disclosed |
| US-20260055506-A1 | HALOGEN COMPOUND | ADEKA CORPORATION (JP) | 2026-02-26 | — | — | US | disclosed |
| US-12516415-B2 | Reactive material and method of producing thin-film | ADEKA CORPORATION (JP) | 2026-01-06 | — | — | US | disclosed |
| US-12509764-B2 | Thin-film forming raw material used in atomic layer deposition method, and method of producing thin-film | ADEKA CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| EP-4660187-A1 | COMPOUND, RAW MATERIAL FOR THIN FILM FORMATION, THIN FILM, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORPORATION (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-12486573-B2 | Thin-film forming raw material, thin-film and method of producing thin-film | ADEKA CORPORATION (JP) | 2025-12-02 | — | — | US | disclosed |
| US-6117487-A | METAL OXIDE FILM FORMED BY VAPOR DEPOSITION | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 2000-09-12 | — | — | US | disclosed |
| US-5980983-A | DEPOSITING A MIXTURE OF METAL BETA-DIKETONATES IN PRESENCE OF OXYGEN, VAPORIZING TO FORM HIGH-PURITY INORGANIC OXIDE LAYER; ELECTRICAL RESISTANCE, HIGH TRANSPARENCY TO LIGHT | THE PRESIDENT AND FELLOWS OF HARVARD UNIVERSITY (US) | 1999-11-09 | — | — | US | disclosed |
| US-5980983-A | DEPOSITING A MIXTURE OF METAL BETA-DIKETONATES IN PRESENCE OF OXYGEN, VAPORIZING TO FORM HIGH-PURITY INORGANIC OXIDE LAYER; ELECTRICAL RESISTANCE, HIGH TRANSPARENCY TO LIGHT | THE PRESIDENT AND FELLOWS OF HARVARD UNIVERSITY (US) | 1999-11-09 | — | — | US | disclosed |
| WO-1998046617-A1 | LIQUID PRECURSOR FOR FORMATION OF METAL OXIDES | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-10-22 | — | — | WO | disclosed |
| WO-1998046617-A1 | LIQUID PRECURSOR FOR FORMATION OF METAL OXIDES | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-10-22 | — | — | WO | disclosed |
| EP-0619833-B1 | RARE EARTH METAL COORDINATION COMPOUNDS AS LACTONE POLYMERIZATION CATALYSTS | DU PONT (US) | 1995-07-12 | — | — | EP | disclosed |
| EP-0619833-A1 | RARE EARTH METAL COORDINATION COMPOUNDS AS LACTONE POLYMERIZATION CATALYSTS. | DU PONT (US) | 1994-10-19 | — | — | EP | disclosed |
| US-5292859-A | Rare earth metal coordination compounds as lactone polymerization catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-03-08 | — | — | US | disclosed |
| WO-1993013155-A1 | RARE EARTH METAL COORDINATION COMPOUNDS AS LACTONE POLYMERIZATION CATALYSTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-07-08 | — | — | WO | disclosed |
| US-5208297-A | Rare earth metal coordination compounds as lactone polymerization catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055506-A1 | HALOGEN COMPOUND | SLC9A2, SLC9A1, SLC9B2 | CHRNB4 3258/4885CHRNA3 2983/4885 |
| US-12509764-B2 | Thin-film forming raw material used in atomic layer deposition method, and method of producing thin-film | FTO, NOS1, NOS3 | CHRNB4 895/4885CHRNA3 1603/4885 |
| US-12630570-B2 | Organometallic adduct compound and method of manufacturing integrated circuit device by using the same | C5, AFF2, AFF4 | CHRNB4 1413/4885CHRNA3 2990/4885 |
| US-20260055507-A1 | THIN-FILM FORMING RAW MATERIAL, THIN-FILM AND METHOD OF PRODUCING THIN-FILM | TMEM109, FTO, YTHDF2 | CHRNB4 506/4885CHRNA3 561/4885 |
| US-12577660-B2 | Compound, thin-film forming raw material, thin-film, and method of producing thin-film | METTL14, YTHDF2, YTHDF1 | CHRNB4 3375/4885CHRNA3 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.